Three Blue Chip Stocks That Have Increased by 380% or More in the Last Five Years
Stock Performance: Nvidia, Oracle, and Eli Lilly have seen significant stock price increases over the past five years, with returns exceeding 380% for investors who bought in 2020, showcasing the potential of blue chip stocks for long-term gains.
Nvidia's Growth: Nvidia has become the most valuable company globally, driven by its leadership in AI chip production, with earnings soaring from under $5 billion to nearly $87 billion in the past year, while maintaining a reasonable forward P/E ratio.
Oracle's Adaptation: Oracle has successfully transitioned to provide cloud infrastructure and AI-related services, with its earnings nearly doubling in three years, and is launching an "Oracle AI Database" to meet evolving customer needs.
Eli Lilly's Innovation: Eli Lilly has transformed its business through the development of GLP-1 drugs for weight loss and diabetes, achieving significant earnings growth and presenting itself as a compelling investment opportunity with a lower forward P/E compared to its peers.
Trade with 70% Backtested Accuracy
Analyst Views on NVDA
About NVDA
About the author

- AI Infrastructure Investment: Nvidia anticipates hyperscaler spending on AI infrastructure will exceed $1 trillion by 2027, with a projected $650 billion in 2026, indicating substantial future revenue growth potential despite market concerns over excessive spending.
- Stock Price Analysis: Nvidia's stock has fallen from above $200 to its current level, down approximately 16% from its highs and only up 6% year-to-date, which is disappointing for investors; however, analysts remain optimistic about its future prospects.
- Earnings Forecast: Analysts project earnings per share of $12.76 for fiscal 2028, which may be conservative given Nvidia's historical growth; using a reasonable earnings multiple of 25, the stock price could reach $319 by the end of fiscal 2028.
- Investment Recommendation: Despite recent stock price declines, analysts believe Nvidia remains an excellent investment opportunity, with expectations that the stock could easily reach $300 by late 2027, offering a potential 50% return, reflecting strong market confidence in its long-term growth.
- Portfolio Adjustment: Under CEO Abel's leadership, Berkshire initiated a stake in Alphabet during Q3 2025, increasing it to nearly 54 million shares, indicating a preference for high-growth tech investments that could enhance returns in the AI sector.
- Exit from Amazon: Berkshire completely exited its long-standing investment in Amazon, reflecting Abel's differentiated strategy among tech giants, which may provide the company with greater investment flexibility and potential returns.
- Strategic Investment in Nvidia: Nvidia's $1 billion investment in Nokia to enhance its AI network infrastructure demonstrates its leadership in the AI ecosystem, potentially offering Berkshire long-term capital appreciation opportunities.
- Profitability and Valuation Appeal: Nvidia's revenue surged due to AI demand, with its stock price appreciating over 1,000% in recent years, and its reasonable P/E ratio positions it as an ideal investment for Berkshire seeking long-term compounding growth.
- Stock Rebound: After significant sell-offs in June, Palantir's stock has rebounded approximately 11% in July, indicating a renewed investor interest in AI software, which may signal a recovery in market confidence.
- Contract Risk: Palantir's contract with the UK's National Health Service (NHS) is set to expire early next year, and the UK Parliament's Science Committee expressed disfavor towards renewal last month, heightening concerns over the $440 million contract's future.
- Investor Dynamics: Notable investor Michael Burry has reduced his short position against Palantir, with news emerging at the end of June, which may have positively influenced the stock's rebound and reflects an improved market sentiment towards the company.
- Analyst Rating Upgrade: DA Davidson upgraded Palantir's rating from neutral to buy on July 2, raising its one-year price target from $165 to $175, indicating analysts' confidence in the company's future growth prospects.
- AI Chip Development: DeepSeek is developing its own AI chip focused on the inference stage, and although still in early stages, it has reached out to chip design, foundry, and memory partners, indicating its ambitions in the AI sector.
- Hiring Trends: The company has quietly increased hiring of chip design engineers without public job postings, reflecting its demand for technical talent and commitment to future development.
- Market Competition Pressure: Due to U.S. export controls limiting Chinese companies' access to Nvidia's advanced chips, DeepSeek has been forced to rely on Nvidia's older H800 and Huawei's Ascend processors, putting it at a technological disadvantage and highlighting the urgent need for in-house chip development to reduce dependency.
- Industry Trends: Huawei currently holds about 50% of China's AI chip market but faces competitive pressure from Alibaba and Baidu, which are also actively developing their own chips, suggesting that DeepSeek's initiatives may further intensify market competition.
- Stock Volatility: Palantir experienced significant sell-offs in June, with its stock price declining as investors shifted focus from AI software to hardware, resulting in a drop in its valuation and reflecting weakened market confidence in AI software companies.
- Contract Renewal Risks: The company's contract with the UK's National Health Service (NHS) is set to expire early next year, and the UK Parliament's Science Committee expressed disfavor towards renewal last month, with the contract valued at approximately $440 million, potentially impacting future revenues negatively.
- Investor Sentiment Shift: Despite facing pressures, Palantir's stock rebounded by about 11% in July, partly due to renowned investor Michael Burry reducing his short position against the company, indicating a recovery in market confidence regarding its future prospects.
- Analyst Rating Upgrade: DA Davidson upgraded Palantir's rating from neutral to buy on July 2, raising its one-year price target from $165 to $175 per share, which could further drive stock price increases due to positive analyst coverage.
- Market Decline: U.S. memory chip stocks fell sharply in Tuesday's premarket trading, with Micron and Western Digital both down 5%, indicating a broader market pessimism that could undermine investor confidence in the semiconductor sector.
- Korean Market Impact: The South Korean stock market briefly entered bear territory due to losses in Samsung Electronics and SK Hynix, which dropped 6.9% and 6.1% respectively, negatively impacting the global memory chip market sentiment.
- Investor Sentiment: Despite the declines in Micron and SanDisk, retail sentiment on Stocktwits was 'extremely bullish' for SanDisk and 'bullish' for Micron and DRAM, suggesting that traders are viewing the dips as potential buying opportunities.
- Profit Booking Phenomenon: Profit-taking was evident in memory stocks, with Micron and SanDisk trading below their peaks from last month, and DRAM prices down 19% from their June 22 high, reflecting a cautious market outlook on short-term profitability.











